Alnylam gets favorable ruling in patent suit against Tekmira

Tue Sep 25, 2012 6:48pm EDT

Related Topics

(Reuters) - Alnylam Pharmaceuticals Inc said a U.S. federal court has ruled that it could sue Canada's Tekmira Pharmaceuticals Corp for infringing patents on lipid nanoparticle technology exclusively licensed to Alnylam.

Alnylam also said it filed a similar lawsuit in Canada.

Alnylam had alleged that Tekmira provided its molecules to pharmaceutical collaborators despite having an exclusive agreement licensing them to Alnylam to use in its RNA therapy.

The company said the U.S. federal court in Massachusetts denied Tekmira's motions to dismiss certain claims by Alnylam.

Alnylam shares closed at $19.38 on the Nasdaq on Tuesday.

(Reporting By Vrinda Manocha in Bangalore; Editing by Don Sebastian)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

A tourist takes a plunge as she swims at Ngapali Beach, a popular tourist site, in the Thandwe township of the Rakhine state, October 6, 2013. Picture taken October 6, 2013. REUTERS/Soe Zeya Tun (MYANMAR - Tags: SOCIETY) - RTR3FOI0

Where do you want to go?

We look at when to take trips, budget considerations and the popularity of multigenerational family travel.   Video